Nu-Med Plus, Inc. (NUMD)
USD 0.07
(-10.52%)
USD 0.07
(-10.52%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 120.52 Thousand USD | -33.84% |
| 2022 | 182.16 Thousand USD | -78.3% |
| 2021 | 839.44 Thousand USD | -57.92% |
| 2020 | 1.99 Million USD | 95.67% |
| 2019 | 1.01 Million USD | -12.82% |
| 2018 | 1.16 Million USD | 150.65% |
| 2017 | 466.51 Thousand USD | -61.9% |
| 2016 | 1.22 Million USD | 28.76% |
| 2015 | 951.06 Thousand USD | -17.02% |
| 2014 | 1.14 Million USD | 390.56% |
| 2013 | 233.63 Thousand USD | -9.52% |
| 2012 | 258.22 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 20.57 Thousand USD | -62.81% |
| 2024 Q2 | 16.03 Thousand USD | -22.06% |
| 2023 Q1 | 26.97 Thousand USD | 321.82% |
| 2023 FY | 120.52 Thousand USD | -33.84% |
| 2023 Q3 | 15.14 Thousand USD | -34.36% |
| 2023 Q2 | 23.07 Thousand USD | -14.45% |
| 2023 Q4 | 55.33 Thousand USD | 265.35% |
| 2022 Q1 | 59.65 Thousand USD | -46.9% |
| 2022 FY | 182.16 Thousand USD | -78.3% |
| 2022 Q4 | 6394.00 USD | -88.99% |
| 2022 Q3 | 58.05 Thousand USD | -0.03% |
| 2022 Q2 | 58.07 Thousand USD | -2.65% |
| 2021 Q3 | 118.36 Thousand USD | -53.03% |
| 2021 FY | 839.44 Thousand USD | -57.92% |
| 2021 Q2 | 251.99 Thousand USD | -29.36% |
| 2021 Q1 | 356.74 Thousand USD | -27.37% |
| 2021 Q4 | 112.34 Thousand USD | -5.09% |
| 2020 Q4 | 491.16 Thousand USD | 9.21% |
| 2020 Q2 | 904.44 Thousand USD | 505.74% |
| 2020 Q3 | 449.75 Thousand USD | -50.27% |
| 2020 FY | 1.99 Million USD | 95.67% |
| 2020 Q1 | 149.31 Thousand USD | -27.41% |
| 2019 Q1 | 423.72 Thousand USD | 26.12% |
| 2019 Q3 | 146.21 Thousand USD | -40.02% |
| 2019 FY | 1.01 Million USD | -12.82% |
| 2019 Q4 | 205.7 Thousand USD | 40.69% |
| 2019 Q2 | 243.78 Thousand USD | -42.47% |
| 2018 Q1 | 142.56 Thousand USD | -3.5% |
| 2018 Q4 | 335.96 Thousand USD | -35.65% |
| 2018 Q3 | 522.06 Thousand USD | 209.44% |
| 2018 Q2 | 168.71 Thousand USD | 18.34% |
| 2018 FY | 1.16 Million USD | 150.65% |
| 2017 Q2 | 111.3 Thousand USD | 59.63% |
| 2017 FY | 466.51 Thousand USD | -61.9% |
| 2017 Q3 | 137.74 Thousand USD | 23.76% |
| 2017 Q4 | 147.74 Thousand USD | 7.25% |
| 2017 Q1 | 69.72 Thousand USD | -75.55% |
| 2016 Q1 | 65.66 Thousand USD | -53.01% |
| 2016 FY | 1.22 Million USD | 28.76% |
| 2016 Q4 | 285.14 Thousand USD | -59.02% |
| 2016 Q3 | 695.81 Thousand USD | 290.99% |
| 2016 Q2 | 177.96 Thousand USD | 171.03% |
| 2015 FY | 951.06 Thousand USD | -17.02% |
| 2015 Q4 | 139.72 Thousand USD | -53.94% |
| 2015 Q3 | 303.36 Thousand USD | -22.07% |
| 2015 Q2 | 389.29 Thousand USD | 228.03% |
| 2015 Q1 | 118.67 Thousand USD | -77.6% |
| 2014 Q2 | 198.3 Thousand USD | 10.79% |
| 2014 FY | 1.14 Million USD | 390.56% |
| 2014 Q1 | 178.98 Thousand USD | 468.76% |
| 2014 Q4 | 529.89 Thousand USD | 121.77% |
| 2014 Q3 | 238.93 Thousand USD | 20.49% |
| 2013 Q3 | 87.74 Thousand USD | 158.78% |
| 2013 Q4 | 31.47 Thousand USD | -64.13% |
| 2013 FY | 233.63 Thousand USD | -9.52% |
| 2013 Q1 | 80.51 Thousand USD | -1.47% |
| 2013 Q2 | 33.9 Thousand USD | -57.89% |
| 2012 Q1 | 19.54 Thousand USD | 0.0% |
| 2012 Q2 | 46.25 Thousand USD | 136.67% |
| 2012 Q4 | 81.71 Thousand USD | -26.19% |
| 2012 Q3 | 110.71 Thousand USD | 139.39% |
| 2012 FY | 258.22 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | 83.728% |
| IR-Med Inc. | 4.89 Million USD | 97.537% |
| Polarean Imaging plc | 12.24 Million USD | 99.016% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 90.873% |
| Avitar, Inc. | 3.56 Million USD | 96.623% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.851% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 82.855% |
| Össur hf. | 396.18 Million USD | 99.97% |
| Zecotek Photonics Inc. | 3.46 Million USD | 96.518% |
| QHSLab, Inc. | 961.65 Thousand USD | 87.467% |
| Wellstar International, Inc. | 1.79 Million USD | 93.284% |
| Össur hf. | 396.18 Million USD | 99.97% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 99.447% |
| Escalon Medical Corp. | 5.25 Million USD | 97.705% |
| Aurora Spine Corporation | 8.65 Million USD | 98.608% |
| BrainsWay Ltd. | 28.01 Million USD | 99.57% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 98.74% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 99.641% |
| Vivos Inc. | 2.78 Million USD | 95.676% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.989% |
| Kelyniam Global, Inc. | 2.27 Million USD | 94.703% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 88.124% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 72.325% |
| Nanomix Corporation | 8.36 Million USD | 98.56% |
| Theraclion SA | 7.43 Million USD | 98.38% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 90.69% |
| Positron Corporation | 1 Million USD | 88.035% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 96.125% |
| Lombard Medical, Inc. | 30.29 Million USD | 99.602% |
| ALR Technologies Inc. | 6.33 Million USD | 98.098% |
| Stratec SE | 46.32 Million USD | 99.74% |
| Vycor Medical, Inc. | 1.27 Million USD | 90.55% |
| Heart Tronics, Inc. | 14.46 Million USD | 99.166% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 41.611% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 99.148% |
| VMS Rehab Systems, Inc. | 63.63 USD | -189316.942% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 96.549% |
| Ingen Technologies, Inc. | 1.88 Million USD | 93.597% |
| Odyssey Group International, Inc. | -14.26 Million USD | 100.845% |
| United American Healthcare Corporation | 59 Thousand USD | -104.281% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 70.422% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 81.01% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 92.892% |
| Urologix, Inc. | 10.09 Million USD | 98.806% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 90.46% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 97.974% |
| SS Innovations International, Inc. | 21.38 Million USD | 99.436% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 47.652% |
| Smith & Nephew plc | 3.46 Billion USD | 99.997% |
| NIOX Group Plc | 22.27 Million USD | 99.459% |
| Fuse Medical, Inc. | 10.35 Million USD | 98.835% |
| Broncus Holding Corporation | 38.15 Million USD | 99.684% |
| Brain Scientific Inc. | 9.66 Million USD | 98.753% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 98.83% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -98.567% |